ESC Professional Premium Access

Antithrombotic strategies in antiphospholipid syndrome with arterial thrombosis: a systematic review and network meta-analysis

Congress Presentation

About the speaker

Doctor Tanawat Attachaipanich

Chiang Mai University, Chiang Mai (Thailand)
0 follower

6 more presentations in this session

A randomized, cross-over study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of milvexian with single and dual antiplatelet therapy in healthy participants

Speaker: Doctor G. Abelian (US)


Effect of low-dose rivaroxaban with low-dose aspirin vs low-dose aspirin on platelet and oxidative biomarkers: a randomized study in diabetes patients with stable peripheral or coronary artery disease

Speaker: Associate Professor B. Rocca (Rome, IT)


Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

Speaker: Doctor K. Matli (Beirut, LB)


CS014 is a novel HDAC inhibitor regulating the platelet activity, fibrinolysis and clot stability for prevention of thrombosis without increased risk of bleeding

Speaker: Associate Professor M. Holinstat (Ann Arbor, US)


Aspirin therapy on prophylactic anticoagulation for hospitalized patients with COVID-19: A propensity score-matched cohort analysis of the HOPE-COVID-19 registry.

Speaker: Doctor F. Santoro (Foggia, IT)


Access the full session

Challenges and advances in antithrombotic therapy

Speakers: Doctor T. Attachaipanich, Doctor G. Abelian, Associate Professor B. Rocca, Doctor K. Matli, Associate Professor M. Holinstat...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb